Intco Medical Technology Co., Ltd. (SHE:300677)
China flag China · Delayed Price · Currency is CNY
49.42
+2.47 (5.26%)
Nov 17, 2026, 3:04 PM CST

Intco Medical Technology Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
298.441,0111,465383629.077,430
Depreciation & Amortization
964.69964.69862.47723.5629.94368.62
Other Amortization
3.483.482.070.031.140.15
Loss (Gain) From Sale of Assets
0.40.4-0.22-0.21-2.37-0.38
Asset Writedown & Restructuring Costs
-303.69-303.69196.6951.0337.5393.05
Loss (Gain) From Sale of Investments
-383.36-383.36-407.52-263.01-151.91-61.12
Other Operating Activities
2,628501.37-103.8326.83-198.2296.04
Change in Accounts Receivable
107.53107.53-1,103-606.63195.71185.55
Change in Inventory
-82.25-82.25-190.52-151.4455.29-240.93
Change in Accounts Payable
224.87224.87385.37430.85-190.87-314.25
Change in Other Net Operating Assets
37.4837.489.638.156.0143.38
Operating Cash Flow
3,3001,8851,079502.411,0658,680
Operating Cash Flow Growth
95.16%74.69%114.78%-52.85%-87.72%1.04%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-1,512-2,575-1,789-1,439-1,715-5,444
Sale of Property, Plant & Equipment
110.27112.532.5416.8167.285.58
Divestitures
-----4.6
Investment in Securities
-8,573-9,380-2,336-2,638-297.13-2,325
Other Investing Activities
587.37390.42255.1383.8678.4528.48
Investing Cash Flow
-9,387-11,452-3,868-3,976-1,867-7,730

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-21,09614,0607,8961,849560.29
Long-Term Debt Repaid
--16,960-8,016-2,312-563.75-438.03
Lease Payments
---2.06---1.75
Net Debt Issued (Repaid)
-445.574,1366,0445,5831,286122.26
Issuance of Common Stock
-148.83--66.45-
Repurchase of Common Stock
-102.28-78.17-25.83---1.41
Common Dividends Paid
-566.46-422.17-338.28-184.92-457.11-1,074
Other Financing Activities
7,6304,593-4,255-2,389-346.04119.95
Financing Cash Flow
6,5168,3781,4253,009549.05-833.25

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-476.5-306.4159.8567.05271.8-41.77
Net Cash Flow
-47.49-1,495-1,304-397.4319.6974.8

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
1,788-689.72-710.37-936.28-649.763,236
Free Cash Flow Growth
------43.12%
Free Cash Flow Margin
13.63%-6.95%-7.46%-13.53%-9.82%19.93%
Free Cash Flow Per Share
2.76-1.07-1.10-1.42-0.984.79
Levered Free Cash Flow
836.44-635.31-1,275-1,447-994.12-230.09
Unlevered Free Cash Flow
1,070-404.59-1,082-1,367-976.33-219.09
Free Cash Flow After Leases
1,788-689.72-712.43-936.28-649.763,235

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
--157.97-440.36-327.53-729.81-335.24
Change in Working Capital
91.4591.45-936.08-418.76120.3753.64